选择性肿瘤动脉插管栓塞及灌注化疗,为中、晚期癌症病人开辟了一条新的治疗途径。但由于体外导管的留置,也给病人带来了诸多不便。70年代初,Blackshear首先设计并研制了皮下植入式输注泵,继而用于临床。随后国内也开展了对药泵的研究并获得成功。我院于1990年9月至1991年11月使用陕西省科联研制的“KL—Ⅰ型皮下埋藏式抗癌药泵”治疗 Selective tumor arterial intubation embolization and perfusion chemotherapy have opened up a new therapeutic approach for patients with advanced and advanced cancer. However, due to the indwelling of the extracorporeal catheter, it also brings inconvenience to the patient. In the early 1970s, Blackshear first designed and developed a subcutaneous implantable infusion pump, which was then used clinically. Subsequently, the research on drug pump was also carried out in China and it was successful. In September 1990 to November 1991, our hospital used the “KL-I type subcutaneously buried anticancer drug pump” developed by Shaanxi Provincial Science and Technology Co., Ltd.